{"bound":false,"session_id":null,"graph_slug":null,"mode":null,"demo_slug":"pembrolizumab_non_small_cell_lung_cancer","demo_question":"What NSCLC indication and PDCD1 target does the graph list for Keytruda (pembrolizumab), what does DailyMed warn about pneumonitis and hepatitis, and what is KEYNOTE-799 (NCT03631784) in Stage III? What is the OS hazard ratio for KEYNOTE-888?","disclaimer":"Public evidence graph demo only — not a medical product. openFDA FAERS values are voluntary reports, not incidence rates, and not causation. Not endorsed by FDA, NLM, NIH, NCBI, Open Targets, or ChEMBL. LLM path is retrieval-only over the graph (no abstract/full-text training dumps)."}